Nutritional composition to promote healthy development and growth

US9439448B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9439448-B2
Application numberUS-201213615701-A
CountryUS
Kind codeB2
Filing dateSep 14, 2012
Priority dateJun 30, 2005
Publication dateSep 13, 2016
Grant dateSep 13, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A nutritional composition for improving the immunological function of a subject, including a lipid or fat; a protein source; about 5 to about 100 mg/100 kcal of a source of long chain polyunsaturated fatty acids which comprises docosahexanoic acid; and about 0.1 to about 1 mg/100 kcal of a prebiotic composition, wherein the prebiotic composition comprises at least 20% of an oligosaccharide which has a fermentation rate which is demonstrably slower than that of galacto-oligosaccharide.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for promoting oral tolerance to food protein antigens in an infant, comprising administering to the infant a nutritional composition comprising a. a lipid or fat; b. a protein source; c. about 5 to about 100 mg/100 kcal of a source of long chain polyunsaturated fatty acids which comprises docosahexanoic acid; d. about 1.0 to about 10.0 g/L of a prebiotic composition, wherein the prebiotic composition comprises at least 20% of an oligosaccharide which has a fermentation rate which is demonstrably slower than that of galacto-oligosaccharide; and e. about 2500 pg to about 10,000 pg TGF-B per mL of composition, wherein the ratio of TGF-β1: TGF-β2 is about 1:1 to about 1:20, and wherein the combination of TGF-β and the prebiotic contributes to the induction of oral tolerance to antigens in an infant, wherein the infant had established oral tolerance to the antigens but oral tolerance has since failed. 2. The method of claim 1 , wherein the prebiotic composition comprises polydextrose. 3. The method of claim 1 , wherein the prebiotic composition further comprises galacto-oligosaccharide. 4. The method of claim 1 , wherein the composition further comprises at least one probiotic. 5. The method of claim 4 , wherein the probiotic is selected from the group consisting of Lactobacillus rhamnosus GG, Bifidobacterium longum , and Bifidobacterium animalis subsp. Lactis BB-12. 6. The method of claim 4 , wherein the probiotic comprises a non-viable probiotic. 7. The method of claim 1 , wherein the nutritional composition further comprises a bioactive-enhanced whey fraction. 8. The method of claim 1 , wherein the nutritional composition further comprises at least one nucleotide selected from the group consisting of cytidine 5′-monophosphate, uridine 5′-monophosphate, adenosine 5′-monophosphate, and guanosine 5′-monophosphate. 9. The method of claim 1 , wherein the protein source comprises glutamine-containing peptides. 10. The method of claim 1 , wherein the protein source comprises from about40% to about 80% whey protein. 11. The method of claim 1 , wherein the protein source comprises from about20% to about 60% casein protein. 12. The method of claim 1 , wherein the protein source comprises intact protein and partially hydrolyzed protein. 13. The method of claim 1 , wherein the protein source comprises hydrolyzed protein having a degree of hydrolysis of between about 4% and 10%.

Assignees

Inventors

Classifications

  • A23L33/40Primary

    Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula · CPC title

  • Fatty acids or derivatives thereof · CPC title

  • Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title

  • Drugs for disorders of the cardiovascular system · CPC title

  • Comminuted fibrous parts of plants, e.g. bagasse or pulp · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9439448B2 cover?
A nutritional composition for improving the immunological function of a subject, including a lipid or fat; a protein source; about 5 to about 100 mg/100 kcal of a source of long chain polyunsaturated fatty acids which comprises docosahexanoic acid; and about 0.1 to about 1 mg/100 kcal of a prebiotic composition, wherein the prebiotic composition comprises at least 20% of an oligosaccharide whic…
Who is the assignee on this patent?
Rosales Francisco J, Van Tol Eric, Rai Gyan P, and 8 more
What technology area does this patent fall under?
Primary CPC classification A23L33/40. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).